Document is current

Article History

Received: 31 July 2025

Accepted: 29 April 2026

First Online: 12 May 2026

Competing interests

: W.C.M. serves as a Scientific Advisory Board (SAB) member and holds stock options from Alzheon, Inc. W.C.M. also serves as an SAB member and holds stock in Acta Pharmaceuticals, Inc. He is a patent holder under the University of California San Diego and Massachusetts General Hospital concerning γ-secretase modulators licensed to Acta Pharmaceuticals, Inc. He has served as a consultant to AC Immune. W.C.M. holds a leadership position in the Trisomy 21 Research Society. He serves on committees for the Alzheimer’s Project San Diego and an NIH COBRE Grant to the University of Nebraska. W.C.M. received a royalty payment under a patent held by Stanford University licensed to Curasen. He served as a paid adviser to Kerna.